BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lv T, Wang Q, Cromie M, Liu H, Tang S, Song Y, Gao W. Twist1-mediated 4E-BP1 regulation through mTOR in non-small cell lung cancer. Oncotarget 2015;6:33006-18. [PMID: 26360779 DOI: 10.18632/oncotarget.5026] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Mikheev AM, Mikheeva SA, Tokita M, Severs LJ, Rostomily RC. Twist1 mediated regulation of glioma tumorigenicity is dependent on mode of mouse neural progenitor transformation. Oncotarget 2017;8:107716-29. [PMID: 29296200 DOI: 10.18632/oncotarget.22593] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
2 Liu Z, Gao W. Leptomycin B reduces primary and acquired resistance of gefitinib in lung cancer cells. Toxicol Appl Pharmacol 2017;335:16-27. [PMID: 28942004 DOI: 10.1016/j.taap.2017.09.017] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
3 Mikheev AM, Mikheeva SA, Severs LJ, Funk CC, Huang L, McFaline-Figueroa JL, Schwensen J, Trapnell C, Price ND, Wong S, Rostomily RC. Targeting TWIST1 through loss of function inhibits tumorigenicity of human glioblastoma. Mol Oncol 2018;12:1188-202. [PMID: 29754406 DOI: 10.1002/1878-0261.12320] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
4 Sun G, Ni K. The Role of Cavin3 in the Progression of Lung Cancer and Its Mechanism. Biomed Res Int 2020;2020:6364801. [PMID: 32352004 DOI: 10.1155/2020/6364801] [Reference Citation Analysis]
5 An X, Hu J, Do KA. SIFORM: shared informative factor models for integration of multi-platform bioinformatic data. Bioinformatics 2016;32:3279-90. [PMID: 27381342 DOI: 10.1093/bioinformatics/btw295] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
6 Qin X, Jiang B, Zhang Y. 4E-BP1, a multifactor regulated multifunctional protein. Cell Cycle. 2016;15:781-786. [PMID: 26901143 DOI: 10.1080/15384101.2016.1151581] [Cited by in Crossref: 97] [Cited by in F6Publishing: 101] [Article Influence: 16.2] [Reference Citation Analysis]
7 Armas-López L, Piña-Sánchez P, Arrieta O, de Alba EG, Ortiz-Quintero B, Santillán-Doherty P, Christiani DC, Zúñiga J, Ávila-Moreno F. Epigenomic study identifies a novel mesenchyme homeobox2-GLI1 transcription axis involved in cancer drug resistance, overall survival and therapy prognosis in lung cancer patients. Oncotarget 2017;8:67056-81. [PMID: 28978016 DOI: 10.18632/oncotarget.17715] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
8 Liu Z, Gao W. Overcoming acquired resistance of gefitinib in lung cancer cells without T790M by AZD9291 or Twist1 knockdown in vitro and in vivo. Arch Toxicol 2019;93:1555-71. [PMID: 30993382 DOI: 10.1007/s00204-019-02453-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
9 Liu Z, Gao W. Synergistic effects of Bcl-2 inhibitors with AZD9291 on overcoming the acquired resistance of AZD9291 in H1975 cells. Arch Toxicol 2020;94:3125-36. [PMID: 32577785 DOI: 10.1007/s00204-020-02816-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
10 Duan F, Hao D, Xu W, Zhong X, Luo T. Correlations of Twist Expression with Pathological and Computed Tomography (CT) Characteristics and Prognosis of Non-Small Cell Lung Cancer (NSCLC). Med Sci Monit 2019;25:977-83. [PMID: 30714578 DOI: 10.12659/MSM.912674] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Li M, Zhang X, Xu X, Wu J, Hu K, Guo X, Zhang P. Clinicopathological and prognostic significance of Twist overexpression in NSCLC. Oncotarget 2018;9:14642-51. [PMID: 29581870 DOI: 10.18632/oncotarget.24489] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
12 Zhang T, Guo J, Li H, Wang J. Meta-analysis of the prognostic value of p-4EBP1 in human malignancies. Oncotarget 2018;9:2761-9. [PMID: 29416809 DOI: 10.18632/oncotarget.23031] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
13 Liu Z, Shah N, Marshall KL, Sprowls SA, Saralkar P, Mohammad A, Blethen KE, Arsiwala TA, Fladeland R, Lockman PR, Gao W. Overcoming the acquired resistance to gefitinib in lung cancer brain metastasis in vitro and in vivo. Arch Toxicol 2021;95:3575-87. [PMID: 34455456 DOI: 10.1007/s00204-021-03147-4] [Reference Citation Analysis]
14 Yu G, Huang B, Chen G, Mi Y. Phosphatidylethanolamine-binding protein 4 promotes lung cancer cells proliferation and invasion via PI3K/Akt/mTOR axis. J Thorac Dis 2015;7:1806-16. [PMID: 26623104 DOI: 10.3978/j.issn.2072-1439.2015.10.17] [Cited by in F6Publishing: 11] [Reference Citation Analysis]